Welcome to the 2nd ESG in Life Sciences Summit Europe

With the CSRD now embedded into national laws and the first reporting deadlines set for Q1 2025, large companies face an urgent need to navigate Europe’s evolving ESG landscape. Meanwhile, the Omnibus package has eased reporting obligations for small and medium-sized enterprises, presenting an unprecedented opportunity to embrace voluntary ESG reporting - not as a burden, but as a strategic advantage. Forward-thinking companies can leverage ESG transparency to enhance investor confidence, mitigate risks, and strengthen stakeholder trust, all while driving sustainable growth on their own terms.

In this era of transformation, businesses must move beyond compliance to unlock the true power of ESG. Success lies in prioritizing the right environmental and social initiatives that align with corporate goals and resources, benchmarking reporting strategies with year-one reporters, and crafting an ESG framework that sets industry standards.

The 2nd ESG in Life Sciences Summit Europe is where ambition meets action. This dynamic event unites senior leaders in ESG, Sustainability, Compliance, Supply Chain, and Finance to explore the future of European ESG reporting—whether mandated or voluntary. From tackling single-use plastics and equitable access to medicine to achieving Scope 3 transparency, this summit is your catalyst for building a market-leading ESG strategy that delivers lasting impact and business value.

Join us in driving the future of Life Sciences sustainability – turning ambition into action, compliance into opportunity, and responsibility into lasting impact for people and the planet.